Methods and compositions for controlling efficacy of RNA silencing
First Claim
Patent Images
1. A method of enhancing RNA silencing activity of an RNAi agent in a mammalian cell or a plant cell comprising:
- (i) selecting a target sequence in an mRNA expressed in the mammalian or plant cell; and
(ii) synthesizing an RNAi agent comprising an antisense strand that is complementary to the target sequence, wherein three, four or five nucleotides within 5 or fewer nucleotides from the 3′
end of the antisense strand are substituted with a nucleotide which does not form a Watson-Crick base pair when the antisense strand is base paired with the target sequence, such that the RNA silencing activity of the RNAi agent is enhanced.
3 Assignments
0 Petitions
Reexamination
Accused Products
Abstract
Based at least in part on an understanding of the mechanisms by which small RNAs (e.g., naturally-occurring miRNAs) mediate RNA silencing in plants, rules have been established for determining, for example, the degree of complementarity required between an RNAi-mediating agent and its target, i.e., whether mismatches are tolerated, the number of mismatches tolerated, the effect of the position of the mismatches, etc. Such rules are useful, in particular, in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing.
-
Citations
30 Claims
-
1. A method of enhancing RNA silencing activity of an RNAi agent in a mammalian cell or a plant cell comprising:
-
(i) selecting a target sequence in an mRNA expressed in the mammalian or plant cell; and (ii) synthesizing an RNAi agent comprising an antisense strand that is complementary to the target sequence, wherein three, four or five nucleotides within 5 or fewer nucleotides from the 3′
end of the antisense strand are substituted with a nucleotide which does not form a Watson-Crick base pair when the antisense strand is base paired with the target sequence, such that the RNA silencing activity of the RNAi agent is enhanced. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30)
-
Specification